Clarity Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Michelle Parker
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.3% |
Management average tenure | 2.6yrs |
Board average tenure | 4.9yrs |
Recent management updates
Recent updates
We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth
Sep 23Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Jan 03We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow
May 29Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth
Aug 24Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation
Jan 13CEO
Michelle Parker
less than a year
Tenure
Ms. Michelle Parker is Executive Director of Clarity Pharmaceuticals Ltd from August 2024 and is its Chief Executive Officer and MD. Ms. Parker joined the Clarity Pharmaceuticals Ltd in June 2018. She serv...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 11yrs | AU$1.22m | 4.9% A$ 110.0m | |
Chief Financial Officer | 2.6yrs | AU$273.61k | no data | |
COO & Non-Independent Executive Director | less than a year | AU$1.02m | 1.35% A$ 30.4m | |
CEO, MD & Executive Director | no data | no data | 0.34% A$ 7.6m | |
Chief Scientific Officer | no data | AU$241.43k | 1.89% A$ 42.5m | |
Director of Corporate Communications. | no data | no data | no data | |
Head of Human Resource | no data | no data | no data | |
Executive Vice President of Operations | no data | no data | no data | |
Chief Medical Officer | no data | no data | no data | |
Company Secretary | no data | AU$268.69k | no data |
2.6yrs
Average Tenure
Experienced Management: CU6's management team is considered experienced (2.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 11yrs | AU$1.22m | 4.9% A$ 110.0m | |
COO & Non-Independent Executive Director | 5.1yrs | AU$1.02m | 1.35% A$ 30.4m | |
CEO, MD & Executive Director | less than a year | no data | 0.34% A$ 7.6m | |
Non-Executive Director | 8.7yrs | AU$86.88k | 5.66% A$ 127.0m | |
Non-Executive Director | 5.7yrs | AU$86.88k | 0.22% A$ 5.0m | |
Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
Lead Independent Non-Executive Director | 14.1yrs | AU$95.72k | 0.056% A$ 1.2m | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 4.7yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 2.6yrs | no data | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data |
4.9yrs
Average Tenure
Experienced Board: CU6's board of directors are considered experienced (4.9 years average tenure).